Esomeprazole and omeprazole may possibly boost the serum concentrations of benzodiazepines (by using CYP2C19 inhibition) leading to greater adverse effects like drowsiness, although the clinical relevance is reduced in most patients – monitor the patient for adverse effects (e.If affected person simply cannot resume their common oral medication p